Inmune Bio Balance Sheet (2017-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)	84.47M	74.81M	66.73M	59.72M	57.41M	52.15M	51.00M	47.83M	41.81M	35.85M	26.00M	31.07M	33.55M	20.92M	19.34M	33.37M	27.73M	24.75M	21.36M	18.41M
Cash & Current Investments (Quarter)	84.47M	74.81M	66.73M	59.72M	57.41M	52.15M	51.00M	47.83M	41.81M	35.85M	26.00M	31.07M	33.55M	20.92M	19.34M	33.37M	27.73M	24.75M	21.36M	18.41M
Receivables - Net (Quarter)		0.30M	0.20M	0.20M	0.10M	0.02M				1.91M		3.14M	1.11M	1.18M	1.28M	1.60M	1.70M	4.28M	0.48M	4.41M
Receivables - Other (Quarter)		0.40M	-0.09M	-0.36M	-0.02M	0.25M	0.03M	-0.28M	0.06M	0.36M	0.56M	0.59M	0.55M	-0.08M	0.13M	0.55M	0.76M	-0.50M	0.29M	0.35M
Receivables (Quarter)		0.70M	0.11M	-0.17M	0.08M	0.27M				2.27M		3.73M	1.65M	1.10M	1.42M	2.15M	2.46M	3.78M	0.77M	4.77M
Prepaid Assets (Quarter)	1.30M	0.01M	4.67M	4.22M	4.60M	4.03M	0.04M	0.03M	1.53M	1.51M	0.02M	1.01M	0.86M	0.33M	0.21M	0.51M	0.47M	0.59M	0.69M	0.62M
Current Assets (Quarter)	90.93M	82.61M	77.06M	70.55M	66.66M	64.67M	56.88M	52.61M	45.61M	39.94M	29.82M	35.49M	35.85M	22.66M	20.96M	36.03M	30.67M	29.89M	22.82M	23.80M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)																0.71M	0.88M	0.95M	0.90M	1.26M
Intangibles (Quarter)	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M
Goodwill & Intangibles (Quarter)	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M
Long-Term Deferred Tax (Quarter)		3.70M				5.44M				19.60M		0.59M	0.55M	25.70M
Other Non-Current Assets (Quarter)	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.13M	0.13M	0.13M	0.11M	0.08M	0.08M	0.08M	0.05M	0.57M	0.75M	0.59M	0.68M	0.54M
Non-Current Assets (Quarter)	16.74M	17.34M	17.29M	17.26M	17.14M	17.12M	17.10M	17.11M	17.09M	17.06M	17.01M	16.96M	16.93M	16.90M	16.84M	-36.03M	2.69M	2.46M	3.00M	3.05M
Assets (Quarter)	107.67M	99.94M	94.35M	87.81M	83.80M	81.80M	73.98M	69.72M	62.70M	57.00M	46.83M	52.45M	52.78M	39.56M	37.80M		33.36M	32.35M	25.82M	26.84M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	4.22M	3.73M	2.55M	0.38M	3.46M	5.21M	2.08M	0.73M	3.67M	7.90M	9.29M	9.28M	10.59M	6.54M	7.20M	7.67M	0.03M	7.77M	4.66M	5.05M
Notes Payables (Quarter)	0.01M	0.08M	0.01M	0.01M	0.01M	0.01M
Payables (Quarter)	4.23M	3.81M	2.56M	0.38M	3.47M	5.21M	2.08M	0.73M	3.67M	7.90M	9.29M	9.28M	10.59M	6.54M	7.20M	7.67M	0.03M	7.77M	4.66M	5.05M
Accumulated Expenses (Quarter)						0.01M	0.01M	0.01M	0.08M	0.04M	0.06M	0.14M	0.06M	0.03M	0.10M	0.18M	0.03M	0.03M	0.03M	0.03M
Other Accumulated Expenses (Quarter)	0.54M	0.47M	0.58M	0.48M	0.78M	0.62M	0.59M	0.56M	0.50M	0.49M	0.52M	0.52M	0.55M	0.52M	0.48M	0.51M
Short term Debt (Quarter)					2.50M	5.00M	7.50M	10.00M	10.00M	9.92M	7.46M	4.98M	2.49M
Current Leases (Quarter)	0.04M	0.14M	0.08M	0.11M	0.14M	0.09M	0.11M	0.10M	0.11M	0.12M	0.12M	0.13M	0.14M	0.14M	0.15M	0.22M	0.46M	0.62M	0.70M	0.81M
Total Current Liabilities (Quarter)	4.81M	4.36M	3.23M	2.29M	6.89M	10.92M	10.28M	13.05M	14.36M	18.46M	17.45M	15.05M	13.82M	7.22M	7.93M	8.59M	7.36M	8.42M	5.39M	5.89M
Non-Current Liabilities
Non-Current Debt (Quarter)	14.40M	14.46M	14.51M	14.57M	12.13M	9.70M	7.26M	4.82M	2.38M		7.50M	5.00M	2.50M	15.00M
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)									0.80M	0.80M	0.80M	0.80M
Non-Current Deferred Tax Liability (Quarter)		0.26M
Operating Leases (Quarter)	0.10M	0.28M	0.77M	0.76M	0.61M	0.61M	0.50M	0.56M	0.43M	0.40M	0.36M	0.32M	0.28M	0.24M	0.20M	0.23M	0.62M	0.41M	1.51M	1.41M
Other Non-Current Liabilities (Quarter)	0.24M					0.55M			0.80M
Total Non-Current Liabilities (Quarter)	19.17M	19.72M	18.71M			21.14M			17.16M
Total Liabilities (Quarter)	19.42M	19.72M	18.71M	17.88M	20.09M	21.69M	18.68M	19.07M	17.97M	18.86M	17.81M	15.37M	14.11M	7.46M	8.13M	8.82M	7.98M	8.83M	6.19M	6.48M
Shareholder's Equity
Total Debt (Quarter)	14.40M	14.46M	14.51M	14.57M	14.63M	14.70M	14.76M	14.82M	12.38M	9.92M	14.96M	9.98M	4.99M	15.00M
Common Equity (Quarter)	88.25M	80.22M	75.64M	69.93M	63.71M	60.10M	55.30M	50.65M	43.93M	37.34M	28.22M	36.28M	38.67M	32.10M	29.67M	28.87M	25.38M	23.52M	19.62M	20.36M
Liabilities and Shareholders Equity (Quarter)	107.67M	99.94M	94.35M	87.81M	83.80M	81.80M	73.98M	69.72M	62.70M	57.00M	46.83M	52.45M	52.78M	39.56M	37.80M		33.36M	32.35M	25.82M	26.84M
Retained Earnings (Quarter)	-54.04M	0.00M	146.19M	-0.70M	-85.18M	-91.01M	-97.55M	155.40M	157.26M	159.14M	-132.05M	-141.79M	193.57M	195.75M	203.10M	226.90M	229.89M	-0.74M	-0.73M	237.69M
Preferred Shares (Quarter)
Treasury Shares (Quarter)									0.08M	0.08M	0.08M	0.08M

Research Tools

Datasets

Plans

Developers

Inmune Bio INMB Balance Sheet (2017-2026)

Research Tools

Datasets

Plans

Developers

Inmune Bio INMB Balance Sheet (2017-2026)

Create an account

Sign In

Reset Password